학술논문

508MO Tarlatamab for patients (pts) with previously treated small cell lung cancer (SCLC): Primary analysis of the phase II DeLLphi-301 study.
Document Type
Article
Source
Annals of Oncology. 2023 Supplement 4, Vol. 34, pS1664-S1665. 2p.
Subject
*SMALL cell lung cancer
Language
ISSN
0923-7534